High-intensity focused ultrasound ablation has been tried successfully in soft-tissue tumors in the breast, prostate, kidneys, and liver. The next frontier is the brain.
High-intensity focused ultrasound ablation has been tried successfully in soft-tissue tumors in the breast, prostate, kidneys, and liver. The next frontier is the brain.
The researchers at Iowa State University have developed a computational model to assess the technique through heterogeneous tissue. A $350,000 grant from the Roy J. Carver Charitable Trust will move the investigators to the next phase: testing the application in humans.
"We need to predict what the ultrasound beam will do when it goes through so many layers of tissue. You want to cook only the tumor and not the surrounding cells," said principal investigator Viren Amin, Ph.D.
Researchers also want to define protocols for specific tumor types and intend to use MR and ultrasound imaging to plan for focused ultrasound treatments.
MRI Long Covid Study Reveals Link Between Lower Pulmonary Gas Exchange and Cognitive Dysfunction
November 26th 2024For patients with Long Covid, lower pulmonary gas exchange may be associated with lower gray and white matter volume, according to new MRI research to be presented at the Radiological Society of North America (RSNA) conference.
New DEXA Scan Study Links Thyroid Medication Levothyroxine to Higher Bone Loss Risk in Seniors
November 25th 2024Use of the medication levothyroxine, commonly prescribed for hypothyroidism, was associated with greater long-term loss of total body bone mass in seniors, according to new DEXA research to be presented at the Radiological Society of North America (RSNA) conference.